Skip to content
LexBuild

CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment

---
identifier: "/us/fr/04-22553"
source: "fr"
legal_status: "authoritative_unofficial"
title: "CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment"
title_number: 0
title_name: "Federal Register"
section_number: "04-22553"
section_name: "CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment"
positive_law: false
currency: "2004-10-07"
last_updated: "2004-10-07"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "04-22553"
document_type: "notice"
publication_date: "2004-10-07"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "69 FR 60157"
fr_volume: 69
---

#  CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) and the Health Resources and Services Administration (HRSA) announce the following committee meeting.

*Name:* CDC/HRSA Advisory Committee on HIV and STD Prevention and Treatment.

*Times and Dates:* 8 a.m.-5 p.m., November 18, 2004. 8 a.m.-12 p.m., November 19, 2004.

*Place:* Doubletree Hotel—Rockville, 1740 Rockville Pike, Rockville, Maryland.

*Status:* Open to the public, limited only by the space available. The meeting room will accommodate approximately 100 people.

*Purpose:* This Committee is charged with advising the Secretary, the Director, CDC, and the Administrator, HRSA, regarding activities related to prevention and control of HIV/AIDS and other STDs, the support of health care services to persons living with HIV/AIDS, and education of health professionals and the public about HIV/AIDS and other STDs.

*Matters To Be Discussed:* Agenda items include issues pertaining to (1) AIDS Drug Assistance Program (ADAP); (2) Ryan White Reauthorization; and (3) Impact of Crystal Methamphetamine on STD rates and HIV. Agenda items are subject to change as priorities dictate.

**FOR FURTHER INFORMATION CONTACT:**

Paulette Ford-Knights, Public Health Analyst, National Center for HIV, STD, and TB Prevention, 1600 Clifton Road, NE., Mailstop E-07, Atlanta, Georgia 30333. Telephone 404/639-8008, fax 404/639-3125, e-mail *[email protected].*

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* Notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry.

Dated: September 30, 2004.

Alvin Hall,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention (CDC).